Covered recipient · General Payments record
SANAM D RAZEGHI
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,730.15
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $458.02 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $120.00 | 1 |
| PFIZER INC. | $106.76 | 5 |
| ABBVIE INC. | $79.94 | 4 |
| Celgene Corporation | $61.79 | 3 |
| Janssen Biotech, Inc. | $34.21 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.44 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.76 | 1 |
| Regeneron Healthcare Solutions, Inc. | $15.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.49 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926019 | CMS |
| ABBVIE INC. | $16.86 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926021 | CMS |
| ABBVIE INC. | $20.28 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926023 | CMS |
| ABBVIE INC. | $24.31 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105926025 | CMS |
| Celgene Corporation | $20.96 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101103618 | CMS |
| Celgene Corporation | $19.65 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101103620 | CMS |
| Celgene Corporation | $21.18 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101103630 | CMS |
| Gilead Sciences, Inc. | $120.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133776545 | CMS |
| Janssen Biotech, Inc. | $14.28 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078570738 | CMS |
| Janssen Biotech, Inc. | $19.93 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078570353 | CMS |
| PFIZER INC. | $22.90 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131194820 | CMS |
| PFIZER INC. | $21.94 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131194816 | CMS |
| PFIZER INC. | $17.40 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131210070 | CMS |
| PFIZER INC. | $22.26 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131477069 | CMS |
| PFIZER INC. | $22.26 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131778708 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.76 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151114777 | CMS |
| Regeneron Healthcare Solutions, Inc. | $15.12 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114144399 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.44 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137660381 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.